Lipogems International

Name: Lipogems International
Address: Viale Bianca Maria, 24, Milan, 20129, IT
Telephone: +390237072408

Casa
Italia
Milan
Lipogems International

Italian based company with head office in Milan which operates globally in the biotechnology and regenerative medicine sectors.

The Lipogems System was invented and developed in Milan, Italy by a world-leading maxillofacial reconstructive plastic surgeon. Lipogems partnered with major research institutions and the best scientists around the world to help understand and investigate the unique characteristics of the micro-fragmented fat obtained with the Lipogems device. Since then, Lipogems has been used in a variety of specialties and over 50,000 patients have received Lipogems around the world. Experience the Difference: Since the launch of Lipogems, patients have experienced the difference in their orthopaedic conditions with this innovative technology through a breakthrough approach that uses their own fat tissue for the repair, reconstruction, replacement of their injured or damaged tissues. Lipogems is dedicated to comprehensive solutions that are transforming patient care and are economical, efficient, and point of care options for physicians and medical facilities.

15/09/2026

Gearing up for a busy September!

The treatment gap doesn’t have an age, activity level, or patient profile.

At Columbia University, physicians are using Lipogems® MicroFat for patients across ages and backgrounds who have tried traditional treatment options but may not be ready—or appropriate—for surgery.

Lipogems® helps expand the treatment continuum—giving physicians another tool to care for patients who might otherwise be left waiting in the gap.

Because “not ready for surgery” shouldn’t mean “out of options.”

04/09/2026

Some of the most challenging pathologies aren’t difficult because we don’t understand the problem.

They’re difficult because there simply aren’t many good treatment options.

When traditional conservative care has provided limited relief, surgery may not be appropriate or desired, or there simply isn’t a clear next step, patients and physicians can find themselves facing a significant treatment gap.

That’s where having another option matters.

Lipogems® MicroFat provides physicians with an FDA-cleared option using the patient’s own adipose tissue. Lipogems technology washes, rinses, and progressively resizes the tissue while preserving its natural microarchitecture—creating an injectable tissue product that can provide cushioning and structural support at sites of damaged or injured tissue.

For challenging pathologies with limited conventional treatment options, expanding the physician’s toolbox can open a different conversation about what may be possible for the patient.

Not every pathology fits neatly into a traditional treatment algorithm.

Sometimes innovation matters most where options are fewest.

28/08/2026

Podium Presentation! Congratulations to Etan P. Sugarman, M.D., FAAOS for his presentation at the Chicago Hip Summit about “Micro-Fragmented Adipose Tissue (MFAT) injections as an alternative biologic to PRP and Stem Cells: Indications, Evidence, and Technical Tips”!

28/07/2026

Not every tissue defect needs to remain a void.

Lipogems® MicroFat is designed to fill areas of missing soft tissue with the patient’s own adipose tissue while preserving its natural microarchitecture. The result is a natural, structural scaffold that conforms to tissue defects and supports the surgeon’s reconstructive strategy.

When structure matters, don’t leave a space—restore it.

Natural tissue. Natural scaffold. Meaningful possibilities.

23/07/2026

The best orthopedic practices don’t lose patients between treatment options—they guide them through every stage of care.

Too often, patients who aren’t ready for surgery leave the practice in search of other solutions. Some never return.

What if they never had to leave?

By integrating Lipogems® into the orthopedic care continuum, practices can provide an additional treatment option for appropriately selected patients while keeping them connected to the physicians they already know and trust.

A comprehensive care pathway may include:
➡️ Physical therapy & rehabilitation
➡️ Medications and injections
➡️ Lipogems® MicroFat
➡️ Arthroscopy or joint preservation procedures with Lipogems MicroFat
➡️ Joint replacement when appropriate

It’s not about replacing surgery—it’s about offering the right treatment at the right time and ensuring patients remain within a coordinated orthopedic ecosystem throughout their journey.

When patients stay in your care continuum, everyone benefits:
✔️ Better continuity of care
✔️ Stronger physician-patient relationships
✔️ Improved patient retention
✔️ More personalized treatment pathways
✔️ Surgery when it’s truly the right next step

Keep patients in your practice. Keep patients connected. Keep patients moving.

23/07/2026

The authors also highlight the importance of evaluating tissue quality—not just cell quantity—through key markers of cellular composition and more.

Success in isn’t simply about harvesting adipose tissue—it’s about preserving its biology. Standardized tissue processing that maintains the native microarchitecture may be just as important as the cells themselves.

Ref: Molecular and Cellular Analysis of Lipogems-Processed Lipoaspirates
for Evaluating the Efficacy of Treatments in Regenerative Medicine

Temple University
University of Campania "Luigi Vanvitelli"

21/07/2026

Why add Lipogems MicroFat to surgery?

Every surgeon knows that the success of a procedure depends on more than surgical technique—it also depends on the quality of the tissue you’re working with.

Poor tissue quality and compromised healing can impact recovery and patient satisfaction.

Lipogems® MicroFat offers a minimally manipulated autologous adipose tissue option that can be incorporated into select surgical procedures. The MicroFat preserved adipose tissue architecture provides cushioning where where it may be clinically appropriate.

For the right patient, surgery doesn’t always have to stand alone. Combining surgical expertise with thoughtful biologic strategies may help support the healing environment.

Lipogems is supported by 230+ independent peer- reviewed publications.

08/07/2026

Your patients aren’t always saying “no” to surgery—they’re often saying “not right now.”

Many patients continue living with pain because they’re the primary provider for their family, caring for loved ones, running a business, or simply can’t take weeks away from work and daily responsibilities.

These patients often fall into the treatment gap—their symptoms persist, but surgery isn’t the right choice for them today.

Rather than losing these patients to other clinics, physicians have an opportunity to keep them engaged with a broader continuum of care. For appropriately selected patients, Lipogems® MicroFat may offer a minimally invasive treatment option that can help bridge the gap while aligning with the patient’s goals, lifestyle, and recovery priorities.

The conversation shouldn’t end when a patient says they’re not ready for surgery.

It should begin with:

“Let’s talk about the options that fit your life today.”

Meeting patients where they are strengthens trust, improves continuity of care, and helps ensure they remain connected to the practice until they’re ready for the next step—whatever that may be.

06/07/2026

The Orthopedic Treatment Gap Is Real.

Too many patients are told to “wait until it’s bad enough” before considering surgery.

But what happens in the months—or even years—in between?

Patients often continue living with pain, reduce their activity, rely on medications, miss work, and experience a declining quality of life.

This is the orthopedic treatment gap—the space between conservative care that is no longer working and surgery that patients aren’t ready for.

It’s time to rethink the care continuum.

By educating patients about evidence-based, minimally invasive treatment options and maintaining ongoing follow-up, healthcare teams can help patients stay active, engaged, and informed while making the right decision for their individual needs.

The goal isn’t to replace surgery—it’s to ensure patients don’t fall through the cracks while they determine what’s best for them.

Every patient deserves options. Every patient deserves a plan.

02/07/2026

The Power of Preserving the Cell & Tissue Microarchitecture

The value of MicroFat isn’t determined by how small the tissue becomes—it’s determined by how much of its native biology is preserved.

It’s a simple principle: preserve the tissue, preserve its potential.

The Lipogems® process is designed to gently wash, rinse and concentrate adipose tissue while helping preserve its native tissue microarchitecture—including the extracellular matrix, microvascular niches, and the natural relationships between cells.

Why does this matter?

A preserved tissue architecture provides a biologic scaffold that supports the tissue’s inherent cellular environment rather than relying on aggressive processing techniques that may disrupt these delicate structures.

This commitment to tissue preservation is one reason Lipogems has become one of the most extensively studied MicroFat technologies, with 230+ peer-reviewed publications, the vast majority conducted independently, and clinical evidence extending to 6.5 years following a single treatment in published studies.

Indirizzo

Viale Bianca Maria, 24
Milan
20129

Telefono

+390237072408

Sito Web

https://www.lipogems.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Lipogems International pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.